NVIDIA
NVDA
Tesla
TSLA
Taiwan Semiconductor
TSM
4
Palantir
PLTR
5
Super Micro Computer
SMCI
US Stock MarketDetailed Quotes
ATNM Actinium
- 1.100
- +0.040+3.77%
Close Mar 4 16:00 ET
- 1.100
- 0.0000.00%
Post 16:20 ET
34.32MMarket Cap-0.79P/E (TTM)
1.120High1.029Low209.77KVolume1.060Open1.060Pre Close224.74KTurnover0.68%Turnover RatioLossP/E (Static)31.20MShares10.24052wk High0.90P/B34.14MFloat Cap1.02952wk Low--Dividend TTM31.04MShs Float450.000Historical High--Div YieldTTM8.57%Amplitude1.029Historical Low1.071Avg Price1Lot Size
About Actinium Company
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.
Company Profile
SymbolATNM
Company NameActinium
Listing DateMar 26, 2014
Founded2000
CEOMr. Sandesh Seth
MarketAMEX
Employees49
Fiscal Year Ends12-31
Address100 Park Avenue,23rd floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10017
Phone1-646-677-3870
Company Executives
- Name
- Position
- Salary
- Sandesh Seth
- Chairman of the Board and Chief Executive Officer
- 4.70M
- Steve O’Loughlin
- Chief Financial Officer, Principal Accounting Officer, Corporate Secretary
- 1.49M
- Dr. June S. Almenoff, F.A.C.P.,M.D.,PhD
- Director
- --
- Dr. David Nicholson, Pd.D
- Lead Independent Director
- 313.00K
- Dr. Jeffrey W. Chell, M.D.
- Independent Director
- 301.00K
- Dr. Ajit S. Shetty, PhD
- Independent Director
- 308.50K
- Richard I. Steinhart
- Independent Director
- 313.00K